Captrust Financial Advisors Meridian Bioscience Inc Transaction History

Captrust Financial Advisors

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$31.15 - $33.39 $1,339 - $1,435	-43 Reduced 0.58%	7,397 $245,000
Q3 2022 Nov 16, 2022	SELL	$30.9 - $33.55 $13,657 - $14,829	-442 Reduced 5.61%	7,440 $235,000
Q2 2022 Aug 16, 2022	BUY	$23.75 - $31.69 $2,375 - $3,169	100 Added 1.29%	7,882 $240,000
Q1 2022 May 16, 2022	BUY	$19.97 - $26.94 $29,855 - $40,275	1,495 Added 23.78%	7,782 $202,000
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $4,033 - $4,991	-231 Reduced 3.54%	6,287 $128,000
Q3 2021 Nov 16, 2021	SELL	$17.35 - $22.5 $9,316 - $12,082	-537 Reduced 7.61%	6,518 $125,000
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $7,005 - $11,016	389 Added 5.84%	7,055 $156,000
Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $95,164 - $143,950	4,816 Added 260.32%	6,666 $175,000
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $1,258 - $1,732	80 Added 4.52%	1,850 $35,000
Q2 2020 Aug 14, 2020	BUY	$7.84 - $23.29 $13,876 - $41,223	1,770 New	1,770 $40,000
Q4 2019 Feb 14, 2020	SELL	$7.9 - $10.14 $34,997 - $44,920	-4,430 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$9.17 - $12.01 $41,540 - $54,405	-4,530 Reduced 50.56%	4,430 $42,000
Q3 2018 Nov 15, 2018	BUY	$14.85 - $16.35 $133,056 - $146,496	8,960 New	8,960 $134,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.